Was Velphoro (sucroferric oxyhydroxide) discontinued?
Velphoro’s status depends on country and supplier. The term “discontinued” can mean either that a manufacturer stopped marketing/supplying the product in a region or that a specific pack size/presentation was withdrawn.
What should patients and prescribers do if Velphoro was stopped where they live?
If Velphoro is no longer available, clinicians typically switch to an alternative phosphate binder for chronic kidney disease–associated hyperphosphatemia (the condition Velphoro is used to treat). The choice usually depends on the patient’s current labs, tolerance, and whether they are also taking calcium-based binders or other agents.
Are there known safety reasons behind a discontinuation?
Discontinuations are sometimes linked to supply/logistics, commercial decisions, or regulatory actions. Without the specific source for the “discontinued” notice you saw (country, date, and whether it was a recall vs. a market withdrawal), the reason can’t be determined from the question alone.
How to confirm whether your specific Velphoro was withdrawn or replaced
Check the notice from one of the following:
- your country’s medicines regulator or national health service alerts
- the pharmacy/distributor message (often lists effective date and substitute products)
- the product’s label/packaging and the date of “market withdrawal” or “discontinuation”
What alternatives might replace Velphoro?
Common phosphate-binder classes used when one product is unavailable include:
- sevelamer (non-calcium binder)
- lanthanum carbonate
- calcium-based binders
- iron-based formulations in some markets (depending on availability and indication)
What questions to ask your nephrologist
If Velphoro availability changed, patients typically ask:
- What binder should I switch to, and why?
- Do I need lab monitoring more often after the switch?
- Should my calcium/phosphate targets or diet advice change?
If you share one detail, I can give a precise answer
Tell me the country (or where you saw the discontinuation notice) and the approximate date, and whether it was “temporarily unavailable,” “withdrawn,” or “market authorization revoked.”